Wall Street hit by tech, oil weakness
Fri, 20 Apr 2018 11:53:03 -0400
(Reuters) - U.S. stock indexes fell on Friday, with Apple leading declines in the technology sector and as energy companies…
Trump rails against high oil prices, OPEC pushes back
Fri, 20 Apr 2018 12:30:35 -0400
WASHINGTON/JEDDAH, Saudi Arabia (Reuters) - U.S. President Donald Trump accused OPEC on Friday of "artificially" boosting oil prices after a…
Wells Fargo agrees to pay $1 billion to settle customer abuses
Fri, 20 Apr 2018 11:44:59 -0400
(Reuters) - Wells Fargo & Co has agreed to pay $1 billion to settle with U.S. regulators who said it…
Trade tensions set for brighter U.S. corporate spotlight
Fri, 20 Apr 2018 12:41:39 -0400
NEW YORK (Reuters) - The potential for an intensifying trade dispute to undercut the U.S. stock market could become clearer…
GE profit tops estimates as cost-cutting kicks in
Fri, 20 Apr 2018 11:59:33 -0400
(Reuters) - General Electric Co posted quarterly results that topped expectations on Friday, as earnings from aviation, healthcare and transportation…
Japan's Takeda sweetens $62 billion Shire offer
Fri, 20 Apr 2018 12:38:49 -0400
TOKYO/LONDON (Reuters) - Japan's Takeda Pharmaceutical nudged up its offer for Shire to 44.3 billion pounds ($62 billion) on Friday…
China trade body urges tighter corporate compliance after ZTE woes: document
Fri, 20 Apr 2018 06:54:28 -0400
BEIJING (Reuters) - A state-backed Chinese trade body said compliance is now a core risk for Chinese firms and that…
Comcast, Charter partner for mobile services back-end software
Fri, 20 Apr 2018 11:46:03 -0400
(Reuters) - Comcast Corp and Charter Communications Inc will partner to develop back-end software to support services for their Xfinity…
PSA union solidarity frays as Opel workers resist cuts
Fri, 20 Apr 2018 12:24:59 -0400
FRANKFURT/PARIS (Reuters) - Planned job cuts at carmaker Opel will save enough cash to meet owner PSA Group's turnaround targets,…
Biogen boosts investment in neurology with $1 billion Ionis deal
Fri, 20 Apr 2018 11:40:19 -0400
(Reuters) - Biogen Inc struck a $1 billion neurology drug development deal with Ionis Pharmaceuticals on Friday, expanding a partnership…